chr1-1090392-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_017891.5(C1orf159):c.109G>A(p.Val37Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000156 in 1,550,074 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017891.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C1orf159 | NM_017891.5 | c.109G>A | p.Val37Ile | missense_variant | 4/10 | ENST00000421241.7 | NP_060361.4 | |
C1orf159 | NM_001330306.2 | c.217G>A | p.Val73Ile | missense_variant | 6/12 | NP_001317235.1 | ||
C1orf159 | NM_001363525.2 | c.109G>A | p.Val37Ile | missense_variant | 5/11 | NP_001350454.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C1orf159 | ENST00000421241.7 | c.109G>A | p.Val37Ile | missense_variant | 4/10 | 2 | NM_017891.5 | ENSP00000400736 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 151886Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000257 AC: 40AN: 155764Hom.: 0 AF XY: 0.000266 AC XY: 22AN XY: 82680
GnomAD4 exome AF: 0.000156 AC: 218AN: 1398188Hom.: 2 Cov.: 32 AF XY: 0.000186 AC XY: 128AN XY: 689620
GnomAD4 genome AF: 0.000158 AC: 24AN: 151886Hom.: 1 Cov.: 33 AF XY: 0.000256 AC XY: 19AN XY: 74166
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2021 | The c.109G>A (p.V37I) alteration is located in exon 4 (coding exon 2) of the C1orf159 gene. This alteration results from a G to A substitution at nucleotide position 109, causing the valine (V) at amino acid position 37 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at